```html

Yaws‑like Skin Disease (Endemic Syphilis): A Comprehensive Medical Guide

Overview

Yaws‑like skin disease, also called endemic syphilis or simply yaws, is a chronic bacterial infection of the skin, bone, and connective tissue caused by the spirochete Treponema pallidum subspecies pertenue. It primarily affects children living in warm, humid tropical regions where poor sanitation and limited access to health care allow the bacterium to spread through skin‑to‑skin contact.

• Geographic distribution: Historically endemic in West, Central, and East Africa, Southeast Asia, the Pacific Islands, and parts of Latin America. The World Health Organization (WHO) estimates that in 2022, > 100,000 new cases were reported worldwide, but true incidence is likely higher because many cases go unreported.
• Age group: 80‑90 % of cases occur in children aged 5–15 years, though adults can be infected, especially when living in the same households or communities.
• Public‑health importance: Yaws is a neglected tropical disease (NTD). If left untreated, it can cause disfiguring skin ulcers and bone deformities, leading to stigma, reduced school attendance, and economic loss.

Because the bacterium is closely related to the one that causes venereal syphilis, laboratory tests can be similar, but the transmission route (non‑sexual) distinguishes endemic syphilis from classic syphilis.

Symptoms

The disease progresses through three clinical stages, each with characteristic manifestations.

1. Primary (Skin) Stage – “Mother‑rash”

• Papular lesion: A painless, raised, pink‑to‑red bump (1–2 cm) that appears at the site of inoculation, often on the legs, feet, or arms.
• Ulceration (yaws ulcer): Within 2–4 weeks, the papule softens and becomes an ulcer with a raised, thickened (“friable”) edge and a clean, yellow‑gray base. The ulcer is typically painless, which may delay recognition.
• Satellite lesions: Smaller ulcer‑like papules may develop around the primary ulcer.

2. Secondary (Disseminated) Stage – “Mucocutaneous eruption”

• Skin rash: Multiple crops of papules, nodules, or plaques that may become crusted. Lesions are commonly found on the trunk, palms, soles, and genital area.
• Condyloma lata‑like growths: Moist, flat, wart‑like lesions in intertriginous zones (groin, armpits).
• Systemic symptoms: Low‑grade fever, malaise, headache, and lymphadenopathy (usually painless).
• Bone pain: In some children, aching in long bones or joints may appear, heralding the early stages of osteitis.

3. Late (Tertiary) Stage – “Yaws‑induced osteitis & deformity”

• Bone involvement: Chronic inflammation of the periosteum leads to thickening of the long bones (especially tibia and femur), causing pain, swelling, and eventual deformities such as “sabre‑shin” (bowed tibia).
• Gummatous lesions: Hard, granulomatous nodules may develop on the skin, periosteum, or cartilage, resembling the gummas of venereal syphilis.
• Joint destruction: Arthritis or joint contractures can limit mobility.
• Scarring: Healed ulcers may leave atrophic or hyperpigmented scars that can be socially stigmatizing.

Symptoms typically appear 2–4 weeks after exposure, and the disease can wax and wane for years if untreated.

Causes and Risk Factors

• Microbial cause: Treponema pallidum subspecies pertenue, a spirochete that cannot be cultured in routine labs.
• Transmission: Direct non‑sexual skin contact with an infectious lesion. The bacterium can survive in moist environments for up to 24 hours, facilitating spread in communal settings (e.g., schools, playgrounds).
• Environmental risk factors:
  • Poor sanitation and limited access to clean water.
  • Overcrowded living conditions and shared clothing or bedding.
  • Warm, humid climate that supports bacterial survival.
• Social risk factors:
  • Living in endemic rural or peri‑urban communities.
  • Lack of routine health‑screening programs.
  • Limited health‑education about skin infections.
• Host susceptibility: Children’s thinner skin and higher propensity for close play increase infection risk.

Diagnosis

Diagnosing yaws involves a combination of clinical assessment, serologic testing, and, when available, molecular methods.

1. Clinical Evaluation

• History of living in or traveling to an endemic area.
• Typical skin lesions (primary ulcer, secondary rash) and bone pain.

2. Serologic Tests

• Non‑treponemal tests: VDRL (Venereal Disease Research Laboratory) or RPR (Rapid Plasma Reagin). These detect antibodies to cardiolipin and are useful for screening and monitoring treatment response.
• Treponemal tests: TPPA (Treponema pallidum particle agglutination), FTA‑ABS (fluorescent treponemal antibody absorption), or rapid treponemal strip tests. Positive treponemal tests confirm exposure to any T. pallidum subspecies.
• Because yaws and venereal syphilis share serologic profiles, a positive result must be interpreted in the epidemiologic context.

3. Molecular Confirmation (where available)

• PCR (polymerase chain reaction): detects T. pallidum pertenue DNA from lesion swabs or tissue biopsies. Recommended for surveillance and when differentiating from other ulcerative diseases.
• Dark‑field microscopy: Direct visualization of spirochetes from ulcer exudate, but requires specialized equipment and expertise.

4. Radiologic Assessment (Late Stage)

• X‑ray or MRI of affected bones to identify periosteal thickening, osteolysis, or deformities.

WHO’s yaws eradication guidelines recommend using a combination of a rapid treponemal test followed by a confirmatory non‑treponemal test for community screening.

Treatment Options

Single‑dose oral azithromycin has become the cornerstone of yaws treatment, dramatically simplifying mass‑drug‑administration (MDA) campaigns. Injectable benzathine penicillin remains an alternative, especially for infants, pregnant women, or when azithromycin resistance is suspected.

1. First‑line Pharmacologic Therapy

• Azithromycin 30 mg/kg (max 2 g) orally, single dose. WHO’s 2020 MDA strategy reported > 95 % cure rates with this regimen.
• Benzathine penicillin G 50,000 IU/kg IM (max 2.4 million IU) single dose. Used where azithromycin is contraindicated (e.g., allergy) or in pregnant women.

2. Alternative or Adjunctive Measures

• Erythromycin: 50 mg/kg/day divided 4 times daily for 10 days – reserved for resistant cases.
• Supportive wound care: Gentle cleaning with saline, topical antibiotic ointment to prevent secondary bacterial infection, and sterile dressings.
• Physiotherapy: For patients with bone deformities or joint contractures, early physiotherapy can preserve range of motion.

3. Follow‑up and Monitoring

• Repeat non‑treponemal test (RPR/VDRL) at 3, 6, and 12 months to confirm serologic decline (≥4‑fold drop).
• Clinical re‑examination of skin lesions at 2 weeks and again at 3 months.
• In the rare event of treatment failure, a second dose of azithromycin or a switch to penicillin is recommended.

Living with Yaws‑like Skin Disease (Endemic Syphilis)

Even after successful treatment, many patients need ongoing care to manage residual scars, bone changes, and psychosocial impacts.

Practical Daily‑Management Tips

• Skin hygiene: Keep lesions clean with mild soap and water; avoid scratching to prevent secondary infection.
• Clothing: Wear loose, breathable fabrics; change socks and underclothing daily to keep skin dry.
• Foot care: Inspect feet each morning for new sores; treat minor cuts promptly.
• Nutrition: Adequate protein, vitamin C, and zinc support wound healing.
• Physical activity: Gentle stretching and weight‑bearing exercises help maintain bone health; avoid high‑impact activities if severe tibial deformity exists.
• School participation: Encourage attendance; inform teachers about the condition to reduce stigma.
• Community support: Join local health‑education groups; share experiences to promote early detection.

Psychosocial Considerations

Visible skin lesions or bone deformities may lead to bullying or social isolation. Counseling, peer‑support groups, and community education can mitigate these effects. In some regions, NGOs provide free prosthetic braces for severe bone deformities.

Prevention

Because yaws spreads through direct skin contact, preventive measures focus on hygiene, early case detection, and community‑wide drug administration.

• Mass‑Drug‑Administration (MDA): WHO recommends annual azithromycin MDA in endemic villages until < 1 case per 10,000 population is achieved.
• Personal hygiene: Regular handwashing with soap, especially after playing outdoors.
• Protective clothing: Long pants and socks reduce exposure of lower limbs, the most common entry site.
• Environmental measures: Improve water supply and sanitation to limit skin maceration that predisposes to ulcer formation.
• Health‑education campaigns: Teach parents and teachers to recognize early lesions and refer promptly.
• Surveillance: Community health workers should report suspected cases to regional health authorities for prompt treatment and contact tracing.

Complications

If left untreated, yaws can progress to severe, disabling sequelae.

• Chronic osteitis and deformities: “Sabre‑shin” and other limb deformities can impair walking and lead to secondary infections.
• Gummatous lesions: Granulomatous tissue may damage skin, bone, or cartilage, resembling advanced venereal syphilis.
• Secondary bacterial infection: Ulcers can become colonized with Staphylococcus or Streptococcus, leading to cellulitis or, rarely, sepsis.
• Stigma and educational loss: Disfiguring lesions often result in school absenteeism and reduced economic opportunity.
• Rare neurologic involvement: Although uncommon, treponemal spread to the central nervous system (neurosyphilis) has been documented in a handful of untreated cases.

When to Seek Emergency Care

References

• World Health Organization. Yaws – Fact Sheet. Updated 2022.
• Centers for Disease Control and Prevention. Syphilis – CDC. 2023.
• Mayo Clinic. Syphilis – Symptoms and Causes. Accessed June 2026.
• National Institutes of Health. Azithromycin treatment for yaws – a systematic review. J Infect Dis. 2022.
• Cleveland Clinic. Syphilis Overview. 2023.
• H. Mitjà et al. “Global Eradication of Yaws: Progress Toward an Ambitious Goal.” *Lancet Infectious Diseases* 2021;21(9):1225‑1235.

```